Myeloid-Derived Regulatory Cells in "Atopic March"

“特应性行军”中的骨髓源性调节细胞

基本信息

项目摘要

PROJECT SUMMARY (See instructions): Objective: The overall goal of this proposal is to test the hypothesis that during allergic airway inflammation, epicutaneous sensitization induces Thymic Stromal Lymphopoeitin (TSLP), a cytokine biomarker for skin barrier defects, which then regulates the recruitment and function of free radical producing-airway myeloid - derived regulatory cells (MDRC), that are critical modulators of airway hyper-responsiveness (AHR). The proposed studies may uncover mechanisms linking MDRC and progression of atopic dermatitis to allergic rhinitis to asthma, the concept called "atopic march". Specific Aims: (1) To test the hypothesis that route of allergen sensitization modulates the recruitment of airway MDRC during allergic airway inflammation via free radical dependent mechanisms (2)To determine whether increase in skin-derived or systemic TSLP levels regulates the activation and/or recruitment of 0 2 . - producing MDRC into allergic airway s and promotes AHR Research Design: Epicutaneous or intraperitoneal sensitization followed by intranasal challenge with ovalbumin induces allergic airway inflammation in the mouse model proposed in this study. MDRC will be analyzed and purified from bronchoalveolar lavage, lung tissue and secondary lymphoid organs at different time points following intranasal antigen challenge to determine their recruitment and function. Genetic knockouts and pharmacologic inhibitors of free radical pathways will be utiized to assess the free-radical mediated regulation of recruitment of MDRC and their potential to control T cell responses and AHR (measured by flexivent). The role of TSLP in modulating recruitment and function of MDRC will be delineated using anti-TSLP antibodies in conjunction with transgenic mice constitutively expressing TSLP. Rationale: Sub populations of NO- and 02.-producing mouse lung MDRC are master regulators of allergic airway inflammation. NO-producing MDRC suppress while 02.-producing MDRC enhances T cell responses and airway hyper-responsiveness. A balance in the ratio of immunosupressive and proinflammatory MDRC is critical for the control of inflammation. Recent studies indicate that high systemic levels of skin-derived TSLP is sufficient to render airway s hypersensitive to allergens. Studies to date have not investigated the potential role of TSLP in regulating the activation and/or recruitment of MDRC into allergic airway s. This study proposes a novel role for MDRC in understanding the relationship between skin barrier dysfunction and the pathogenesis of allergic asthma.
项目摘要(见说明):目的:本提案的总体目标是检验以下假设:在过敏性气道炎症期间,表皮致敏诱导胸腺基质细胞生成素(TSLP),一种皮肤屏障缺陷的细胞因子生物标志物,其然后调节产生自由基的气道髓源性调节细胞(MDRC)的募集和功能,是气道高反应性(AHR)的关键调节剂。这项研究可能揭示MDRC与特应性皮炎、过敏性鼻炎和哮喘进展之间的联系机制,即所谓的“特应性进展”。具体目标:(1)验证过敏原致敏途径通过自由基依赖性机制调节过敏性气道炎症过程中气道MDRC的募集。(2)确定皮肤来源或全身TSLP水平的增加是否调节0 2的激活和/或募集。- 在过敏性气道中产生MDRC并促进AHR研究设计:在本研究中提出的小鼠模型中,表皮或腹膜内致敏后用卵清蛋白鼻内激发诱导过敏性气道炎症。将在鼻内抗原激发后的不同时间点从支气管肺泡灌洗液、肺组织和次级淋巴器官中分析和纯化MDRC,以确定其募集和功能。自由基途径的基因敲除和药理学抑制剂将用于评估自由基介导的MDRC募集调节及其控制T细胞应答和AHR(通过flexivent测量)的潜力。TSLP在调节MDRC的募集和功能中的作用将使用抗TSLP抗体结合组成型表达TSLP的转基因小鼠来描述。依据:NO-和02.-的亚群产生小鼠肺MDRC是过敏性气道炎症的主要调节剂。NO生成MDRC抑制,而02.-产生MDRC增强T细胞应答和气道高应答性。免疫抑制和促炎MDRC的比例平衡对于控制炎症至关重要。最近的研究表明,高全身水平的皮肤来源的TSLP足以使气道对过敏原过敏。迄今为止的研究尚未调查TSLP在调节MDRC活化和/或募集到过敏性气道中的潜在作用。这项研究提出了一个新的作用MDRC在了解皮肤屏障功能障碍和过敏性哮喘的发病机制之间的关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessy Satyadas Deshane其他文献

Jessy Satyadas Deshane的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessy Satyadas Deshane', 18)}}的其他基金

Modeling Dynamic Immune Cell Modulation in a 3-D Tissue Engineered Platform to Enhance Patient-specific Immunotherapy for Lung Cancer
在 3D 组织工程平台中模拟动态免疫细胞调节,以增强肺癌患者特异性免疫治疗
  • 批准号:
    10518637
  • 财政年份:
    2022
  • 资助金额:
    $ 3.88万
  • 项目类别:
Modeling Dynamic Immune Cell Modulation in a 3-D Tissue Engineered Platform to Enhance Patient-specific Immunotherapy for Lung Cancer
在 3D 组织工程平台中模拟动态免疫细胞调节,以增强肺癌患者特异性免疫治疗
  • 批准号:
    10672244
  • 财政年份:
    2022
  • 资助金额:
    $ 3.88万
  • 项目类别:
Project 2Asthma in Children Exposed to Heavy Metals
项目 2 接触重金属的儿童患哮喘
  • 批准号:
    10337088
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
Project 2Asthma in Children Exposed to Heavy Metals
项目 2 接触重金属的儿童患哮喘
  • 批准号:
    10560535
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
Myeloid-Derived Regulatory Cells in Asthma
哮喘中的骨髓源性调节细胞
  • 批准号:
    9104514
  • 财政年份:
    2016
  • 资助金额:
    $ 3.88万
  • 项目类别:
Myeloid-Derived Regulatory Cells in Asthma
哮喘中的骨髓源性调节细胞
  • 批准号:
    9924627
  • 财政年份:
    2016
  • 资助金额:
    $ 3.88万
  • 项目类别:
Myeloid regulatory cells in allergic airway inflammation
过敏性气道炎症中的骨髓调节细胞
  • 批准号:
    7753950
  • 财政年份:
    2009
  • 资助金额:
    $ 3.88万
  • 项目类别:
Myeloid-Derived Regulatory Cells in "Atopic March"
“特应性行军”中的骨髓源性调节细胞
  • 批准号:
    8524199
  • 财政年份:
  • 资助金额:
    $ 3.88万
  • 项目类别:

相似海外基金

Study on the Effects of Activation-induced cell death of ILC2s in Patients with Allergic Rhinitis
ILC2s激活诱导细胞死亡对变应性鼻炎患者影响的研究
  • 批准号:
    23K08954
  • 财政年份:
    2023
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New mechanisms of sublingual immunotherapy for the treatment of allergic rhinitis
舌下免疫治疗治疗变应性鼻炎的新机制
  • 批准号:
    22H03233
  • 财政年份:
    2022
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Testing the effectiveness of the biological drug, Tezepelumab, in patients with coexisting allergic rhinitis and allergic asthma
测试生物药物 Tezepelumab 对同时患有过敏性鼻炎和过敏性哮喘的患者的有效性
  • 批准号:
    490921
  • 财政年份:
    2022
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Studentship Programs
The analysis of T follicular helper and regulatory cells of patients with atopic asthma comorbid with allergic rhinitis by treated with HDM-SLIT
HDM-SLIT治疗特应性哮喘合并变应性鼻炎患者滤泡辅助T及调节细胞分析
  • 批准号:
    21K08441
  • 财政年份:
    2021
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of Neuromedin U in the pathogenesis of allergic rhinitis and analysis for innovative drug discovery.
Neuromedin U 参与过敏性鼻炎的发病机制以及创新药物发现的分析。
  • 批准号:
    20K09720
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of clock genes and associated pathologies in the regulation of allergic rhinitis condition via the activation of Sirtuin1 signalling pathway.
时钟基因和相关病理通过激活 Sirtuin1 信号通路调节过敏性鼻炎病情的机制。
  • 批准号:
    20K18301
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effect of IL-33 Gene Expression suppression on allergic rhinitis
IL-33基因表达抑制对变应性鼻炎的影响
  • 批准号:
    20K09693
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Treatment of allergic rhinitis with intranasal NB-UVB irradiation
鼻内NB-UVB照射治疗过敏性鼻炎
  • 批准号:
    20K18254
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidating the Effects of Aging Changes on the Pathophysiology of Allergic Rhinitis
阐明衰老变化对过敏性鼻炎病理生理学的影响
  • 批准号:
    20K22995
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Novel diagnostic and preventive methods for allergic rhinitis using epigenetic analysis of nasal epithelial cells
利用鼻上皮细胞表观遗传学分析诊断和预防过敏性鼻炎的新方法
  • 批准号:
    20K18275
  • 财政年份:
    2020
  • 资助金额:
    $ 3.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了